Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-3120
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStarossom, Sarah-Christin
dc.date.accessioned2011-08-03T10:21:05Z
dc.date.available2011-08-03T12:21:05Z
dc.date.issued2011
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/3122-
dc.description.abstractInflammation-mediated neurodegeneration occurs in the acute and the chronic/progressive phases of multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Classically-activated microglia (M1) are key players mediating this process through secretion of soluble factors including nitric oxide (NO) and tumor necrosis factor (TNF). Here, galectin-1, an endogenous glycan-binding protein, was identified as a pivotal regulatory mechanism that limits M1 microglia activation and neurodegeneration, by targeting the activation of p38MAPK- and CREB-dependent pathways and hierarchically controlling downstream pro-inflammatory mediators such as iNOS, TNF and CCL2. Galectin-1 is highly expressed in the acute phase of EAE and its targeted deletion results in pronounced inflammation-induced neurodegeneration. These findings identify an essential role of galectin-1-glycan lattices in tempering microglia activation, brain inflammation and neurodegeneration with critical therapeutic implications in relapsing-remitting and secondary progressive MS.rnMicroglia with distinct phenotypes are implicated in neurotoxicity, neuroprotection, and in modulation of endogenous repair by NSCs. However the precise molecular mechanisms underlying this diversity in fuction are still unknown. rnUsing a model of EAE, transcriptional profiling of isolated SVZ microglia from the acute and chronic disease phases of EAE was performed. The results from this study suggest that microglia exhibit disease phase specific gene expression signatures, that correspond to unique GO functions and genomic networks. These data demonstrate for the first time, distinct transcriptional networks of microglia activation in vivo, that support their role as mediators of injury or repair.en_GB
dc.language.isoeng
dc.rightsInCopyrightde_DE
dc.rights.urihttps://rightsstatements.org/vocab/InC/1.0/
dc.subject.ddc500 Naturwissenschaftende_DE
dc.subject.ddc500 Natural sciences and mathematicsen_GB
dc.titleThe role of microglia in neurodegeneration and endogenous repair during experimental autoimmune encephalomyelitisen_GB
dc.typeDissertationde_DE
dc.identifier.urnurn:nbn:de:hebis:77-28014
dc.identifier.doihttp://doi.org/10.25358/openscience-3120-
jgu.type.dinitypedoctoralThesis
jgu.type.versionOriginal worken_GB
jgu.type.resourceText
jgu.organisation.departmentFB 10 Biologie-
jgu.organisation.year2011
jgu.organisation.number7970-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.organisation.placeMainz-
jgu.subject.ddccode500
opus.date.accessioned2011-08-03T10:21:05Z
opus.date.modified2011-08-18T09:08:49Z
opus.date.available2011-08-03T12:21:05
opus.subject.dfgcode00-000
opus.organisation.stringFB 10: Biologie: Abteilung Molekulare Zellbiologie / Biologie für Medizinerde_DE
opus.identifier.opusid2801
opus.institute.number1004
opus.metadataonlyfalse
opus.type.contenttypeDissertationde_DE
opus.type.contenttypeDissertationen_GB
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
2801.pdf109.18 MBAdobe PDFView/Open